Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novartis AG

107.54
+2.392.27%
Volume:1.46K
Turnover:158.86K
Market Cap:214.97B
PE:16.86
High:107.54
Open:107.54
Low:107.54
Close:105.15
Loading ...

Company Profile

Company Name:
Novartis AG
Exchange:
PINK
Establishment Date:
1996
Employees:
75883
Office Location:
Lichtstrasse 35,Basel,Basel-Stadt,Switzerland
Zip Code:
4056
Fax:
41 61 324 80 01
Introduction:
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.